🔎 Trials Near Me

Gara Jalqabaatti › Baayyee Ulfaataa › Tennessee › Memphis

Qorannoo klinikaalii Baayyee Ulfaataa Memphis, TN keessatti

Qorannoo 8 Baayyee Ulfaataa f Memphis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Stern Cardiovascular Foundation Inc, Germantown · Miili 14 fagaatti
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Namoota walitti qabaa jiraSadarkaa 3
  • LifeDoc Health, Memphis
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • Gastroenterology Center Of The Midsouth, Cordova · Miili 15 fagaatti
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Namoota walitti qabaa jiraSadarkaa 3
  • Gastroenterology Center Of The Midsouth, Cordova · Miili 15 fagaatti
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-2 Clinical Site, Memphis
  • AURORA-2 Clinical Site, Olive Branch · Miili 18 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-1 Clinical Site, Memphis
  • AURORA-1 Clinical Site, Olive Branch · Miili 18 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Olive Branch Family Medical Center, Olive Branch · Miili 18 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailea Clinical Site, Memphis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Qorannoo Baayyee Ulfaataa magaalota biroo keessatti

Qorannoo biroo Memphis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.